Capzanine has made its first investment in Spain providing MBA, a Spanish orthopaedic prostheses and trauma products distributor, with a EUR25 million unitranche facility.
Founded in 1988 in Asturias, Spain, MBA differentiates itself from competitors through its offering of a wide range of products, a qualified and specialised sales team, and a surgeon-focused strategy.
Capzanine’s main investment fundamentals in MBA are the company’s well-established leadership position and its confidence in Alantra (majority shareholder) and in the management team of the company, led by Carlos Marina. This EUR25m unitranche facility will allow MBA to reorganise its capital structure and to finance its growth plans, whose basic pillars are the commitment to provide a differential service to the healthcare sector professionals and to efficiently management its portfolio, betting on innovative and high value-added products.
José Tomás Moliner, Capzanine’s Country Head of Spain, says: “MBA has a top-level management team that has been able, with the support of Alantra, to consolidate the company’s position as the undisputed leader in the distribution of prostheses and surgical material in Iberia and Italy. This is an industry Capzanine knows well thanks to our multiple investments in the sector. “
Laurent Bénard, General Manager of Capzanine, adds: “We are very pleased to partner with MBA as the first transaction of our private debt fund in Spain. Capzanine has a strong interest to keep investing in the Spanish mid-market and support growing companies, via both our Private Debt and our Private Equity funds. “
Carlos Marina, CEO of MBA, says: “MBA’s financial health has allowed the company to perform this refinancing. This transaction has 2 main advantages for the group: firstly, it will allow MBA’s management team to focus on operations, growth and profitability, and secondly it will allow the company to leverage on Capzanine’s experience in this sector.
